CTXII: Cross Linked C-telopeptide of Type II Collagen - A Critical Biomarker of Cartilage Degradation
Endocrinology Diagnostics
Key Summary of CTXII (Cross-Linked C-telopeptide of Type II Collagen):
Molecular Structure
- Breakdown product of type II collagen in cartilage
- Formed by enzyme-mediated cleavage from matrix metalloproteinases
- Unique structural configuration enables specific tracking of cartilage metabolism
Biological Significance
- Biomarker for cartilage wear and tear
- Metabolized through body fluids and excreted via urine
- Levels influenced by age, gender, hormones, and physical activity
Analytical Methods
- Measured using ELISA technique
- Preferably tested using second morning urine samples
- Levels typically adjusted based on creatinine concentration
Clinical Applications
- Indicates severity and progression of osteoarthritis
- Useful in tracking rheumatoid arthritis joint damage
- Helps predict vulnerability to joint deterioration
- Beneficial in assessing sports injuries and joint developmental issues
Interpretation Considerations
- Requires context of age, existing health conditions, and medications
- Most effective when combined with other biomarkers and clinical evaluations
- Ongoing research aims to improve measurement precision
Visit the BioSupply Ltd website for more information on CTXII: Cross Linked C-telopeptide of Type II Collagen - A Critical Biomarker of Cartilage Degradation